Clindamycin Phosphate
- Product NDC
- 53002-8371
- 11-digit product format
- 530028371
- Labeler code
- 53002
- Product ID
- 53002-8371_37655ff1-ab83-4ad8-9fd1-e9da45f7d8cc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Clindamycin Phosphate
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA208767
- Marketing category
- ANDA
- Marketing start
- 2020-06-15
- Marketing end
- 0000-00-00
- Substance
- CLINDAMYCIN PHOSPHATE
- Active strength
- 10 mg/mL
- Pharmacologic classes
- Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-8371-1 | 53002837101 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (53002-8371-1) > 30 mL in 1 BOTTLE, WITH APPLICATOR | 2022-12-01 | 0000-00-00 | No | No | Current |